Agilvax

Developing stem cell immunotherapies for cancer

placeAlbuquerque, New Mexico, United States calendar_todayFounded 2011 groups6 employees language agilvax.com

Innovation

3 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 136 times.

YearFilings
20182
20192
20203
20212
20221

Investor mix

7 investors on record; lead investors include J Hunt Holdings.

Investor typeCountShare
Venture capital229%
Private equity114%
Accelerator & incubator229%
Other / undisclosed229%
Coming soon